EchoSolv AS will be fully integrated into ScImage’s medical workflow platform, facilitating streamlined deployment within MedAxiom’s hospital and cardiology networks.
AI and Medical Technology company Echo IQ is pleased to advise of significant Partnership and Integration Agreements with ScImage and MedAxiom, two leading US healthcare technology providers. This collaboration will considerably expand the distribution of EchoSolv AS, integrating its advanced AI-powered cardiology technology across an extensive network of hospitals and cardiology practices in the United States.
Under the agreement, EchoSolv AS will be initially deployed across 36 MedAxiom/ScImage-affiliated hospitals and cardiology practices, enabling physicians to access advanced AI-driven diagnostics through ScImage’s industry-leading image management and workflow platform. By leveraging ScImage’s agile cloud- native architecture, EchoSolv AS will be delivered seamlessly for easy user adoption. This partnership significantly expands EchoSolv AS’ presence in the US market, providing broader access to cutting-edge technology for early, accurate detection of severe aortic stenosis.
This agreement solidifies Echo IQ’s position as a key innovator in AI-driven cardiovascular disease detection, reinforcing its commitment to advancing patient outcomes through cutting-edge technology and strategic partnerships.
Also Read: Pleio Unveils OLLIE™: AI for Human Connection in Care
Management Commentary:
Founder and CEO of ScImage, Inc., Dr Sai Raya PhD, said: “We are proud to be making Echo IQ’s extraordinary capabilities available to our customers. Both companies share a vision of technology-powered tools that enhance cardiology as well as patient outcomes. The limitless benefits of AI technology represent ScImage’s continued commitment to improving efficiency and ensuring our partners’ patients have access to the best technology available. I am confident our customers will embrace the benefits of seamless integration with this ground-breaking AI technology.”
Echo IQ‘s Chief Executive Officer, Mr Dustin Haines, said: “This partnership marks a pivotal milestone in our mission to transform cardiovascular diagnostics in the US. By integrating EchoSolv AS into ScImage‘s workflow platform and deploying it across MedAxiom‘s extensive network, we are ensuring that more physicians have access to innovative, AI-driven solutions to detect and manage severe aortic stenosis. This partnership further supports our approach of prioritising integrations in the lead up to our CATIII reimbursement. We look forward to deepening our collaboration and expanding access to this life-saving technology across more hospital networks nationwide.”
Source: PRNewswire
